Sign in
4

Changes in Ownership

ORAMED PHARMACEUTICALS INC. Filed Acc 0001213900-22-000818

President and CEO gave up 48,752 shares (to pay taxes)

  • President and CEO acquired 213,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
KIDRON NADAV President and CEO 2022-01-03 Grant or award +150,000 936,481 D: show line 1 in the form
KIDRON NADAV President and CEO 2022-01-03 Shares withheld for taxes −48,752 $13.89 $677,165 887,729 D: show line 2 in the form
KIDRON NADAV President and CEO 2022-01-03 Grant or award +63,000 950,729 D: show line 3 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
KIDRON NADAV President and CEO 2022-01-03 Grant or award · Stock Option (right to buy +107,000 107,000 D: show line 4 in the form
Loading xslF345X03/ownership.xml…